MorphoSys AG Reports First Quarter 2019 Results
Conference call and webcast (in English) to be held on May 8, 2019 at 2:00pm CEST (1:00pm BST/8:00am EDT) -...
Conference call and webcast (in English) to be held on May 8, 2019 at 2:00pm CEST (1:00pm BST/8:00am EDT) -...
Established doctor and philanthropist Jan McBarron is committed to ensuring that deserving students in the field of health and medicine...
SAN DIEGO, CA / ACCESSWIRE / May 7, 2019 / Calidi Biotherapeutics, Inc. is happy to announce the United States...
Industry leading solution delivers deeper insights into financial performance, revenue opportunities and problem areas. LITTLE ROCK, Ark.--(BUSINESS WIRE)--MedEvolve, Inc., a...
Fighting the allergic reaction to anything new with #neuschnupfenBrussels, Belgium | Hamburg, Germany, May 7, 2019. While online banking, ordering...
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its...
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Appeals Court Set to Hear and Then Decide DECN's Seminal Legal Question at Issue in Long Simmering Patent Battle with...
CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
HAMBURG, GERMANY / ACCESSWIRE / May 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
WINNIPEG, MB / ACCESSWIRE / May 7, 2019 / Preferred Dental Technologies Inc. (PDTI) has been granted an additional patent...
Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May...
TORONTO, ON / ACCESSWIRE / May 7, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Program is open to two patients who completed CTD's clinical trial with Trappsol® Cyclo™ in the United States ALACHUA, FL...
OrthoIllinois Advances Highly Efficient Operating Model with HSTpathways Software SAN FRANCISCO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/ASC?src=hash" target="_blank"gt;#ASClt;/agt;--HSTpathways, the leading provider of cloud-based, ambulatory...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/holx?src=hash" target="_blank"gt;#holxlt;/agt;--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences:...
BOSTON--(BUSINESS WIRE)--Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointment of Jeffrey Ecsedy, Ph.D.,...
Tennessee provider seeks to make genomic information easily available at the point of care PITTSBURGH & CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions,...